Department of Internal Medicine C, Shamir Medical Center, Shamir Medical Center (Assaf Harofeh), Zerifin, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Isr Med Assoc J. 2021 Apr;23(4):212-213.
Coronavirus disease-2019 (COVID-19) is recognized as a respiratory illness, which includes pulmonary consolidations, hypoxemic states, and hypercoagulopathic tendencies with a broad clinical severity. Recently, more reports have described post-infection manifestations. These include multi-system inflammatory syndrome in children (MIS-C) with more than 400 cases published since the start of the coronavirus disease pandemic. In October 2020, the U.S. Centers for Disease Control and Prevention (CDC) published 27 cases [1] describing the new multi-system inflammatory syndrome in adults (MIS-A). Nine of the cases were reported directly to the CDC, 7 from published case reports and another 11 patients found in three distinct case series.
2019 年冠状病毒病(COVID-19)被认为是一种呼吸道疾病,包括肺部实变、低氧血症和广泛的临床严重程度的高凝倾向。最近,更多的报告描述了感染后的表现。这些包括儿童多系统炎症综合征(MIS-C),自冠状病毒病大流行开始以来已发表了超过 400 例。2020 年 10 月,美国疾病控制与预防中心(CDC)发表了 27 例[1]描述了成人(MIS-A)的新型多系统炎症综合征。其中 9 例直接向 CDC 报告,7 例来自已发表的病例报告,另有 11 例患者在三个不同的病例系列中发现。